The results of the CATT trial demonstrated that Avastin and Lucentis are equally effective for the treatment of wet macular degeneration. A small issue, since the release of that data, appears to be whether Avastin has more side effects than Lucentis.
Avastin is as safe (or as dangerous) as Lucentis.
The CATT trial results were data from the first year of a 2 year study. The results from the 1 year data of th (Read more...)